IPMN, particularly those driven by KRAS and GNAS mutations, has been shown to rely on fatty acid oxidation (FAO) as a primary metabolic adaptation (41). The gene discussed is GNAS; the disease is pancreatic intraductal papillary-mucinous neoplasm.